المؤلفون: Massimo Aglietta, Tomislav Dragovich, Sara Lonardi, Michael J. Overman, Jean-Marie Ledeine, Usman Shah, Dana Backlund Cardin, Alain Hendlisz, Eric Van Cutsem, J. Gricar, María Luisa Limón, Sandzhar Abdullaev, Bart Neyns, Gabriele Luppi, Ka Yeung Mark Wong, Pilar García-Alfonso, Heinz-Josef Lenz

المساهمون: Clinical sciences, Medical Oncology, Laboratory for Medical and Molecular Oncology, Laboratory of Molecullar and Cellular Therapy

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(2)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Time Factors, CheckMate 142, Colorectal cancer, First line, Ipilimumab, DNA Mismatch Repair, Food and drug administration, Young Adult, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm Metastasis, Immune Checkpoint Inhibitors, Aged, Aged, 80 and over, business.industry, metastatic colorectal cancer, Low dose, Microsatellite instability, Middle Aged, medicine.disease, Progression-Free Survival, Treatment, Nivolumab, Disease Progression, DNA mismatch repair, Female, Microsatellite Instability, MSI-H/dMMR, business, Colorectal Neoplasms, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e637ee03e80d0fbd9e63fbfd55484c1f
https://pubmed.ncbi.nlm.nih.gov/34697487

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.